The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Docetaxel
Docetaxel · DOCETAXEL 20 mg/mL · Injection, Solution, Concentrate · Intravenous · Meitheal Pharmaceuticals Inc.
NDC 71288-0133-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $480.15 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA213768
- TE code
- —
- Approval date
- May 13, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Docetaxel (Injection, Solution, Concentrate)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actavis Pharma, Inc. | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Hikma Pharmaceuticals USA Inc. | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Accord Healthcare Inc. | DOCETAXEL ANHYDROUS 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | DOCETAXEL 160 mg/8mL | Jul 15, 2026 | Sep 2, 2026 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | DOCETAXEL 80 mg/4mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sanofi-Aventis U.S. LLC | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sanofi-Aventis U.S. LLC | DOCETAXEL 160 mg/8mL | Jul 15, 2026 | Sep 2, 2026 |
| Sanofi-Aventis U.S. LLC | DOCETAXEL 80 mg/4mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | DOCETAXEL 20 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Docetaxel — NDC 71288-0133-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71288013301.
Free to cite with attribution — see how the data is put together.